Mesoporous silica nanoparticles: a potential platform for generation of induced pluripotent stem cells?

Abstract

NanomedicineVol. 9, No. 4 EditorialMesoporous silica nanoparticles: a potential platform for generation of induced pluripotent stem cells?Shih-Hwa Chiou, Shih-Fan Jang & Chung-Yuan MouShih-Hwa ChiouInstitute of Pharmacology, National Yang-Ming University, Taipei 112, TaiwanInstitute of Clinical Medicine, National Yang-Ming University, Taipei 112, TaiwanDepartment of Medical Research and Education, Taipei Veterans General Hospital, Taipei 112, TaiwanSearch for more papers by this author, Shih-Fan JangInstitute of Pharmacology, National Yang-Ming University, Taipei 112, TaiwanDepartment of Medical Research and Education, Taipei Veterans General Hospital, Taipei 112, TaiwanSearch for more papers by this author & Chung-Yuan MouAuthor for correspondence: E-mail Address: cymou@ntu.edu.twDepartment of Chemistry, National Taiwan University, Taipei 106, TaiwanSearch for more papers by this authorPublished Online:1 May 2014https://doi.org/10.2217/nnm.14.9AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInRedditEmail View articleKeywords: direct reprogramminginduced pluripotent stem cellsmesoporous silica nanoparticlesnonviral conversionReferences1 Jarnbhrunkar S, Yu MH, Yang J et al. Stepwise pore size reduction of ordered nanoporous silica materials at angstrom precision. J. Am. Chem. Soc. 135(23), 8444–8447 (2013).Crossref, Medline, Google Scholar2 Kuthati Y, Sung P J, Weng CF, Mou CY, Lee CH. Functionalization of mesoporous silica nanoparticles for targeting, biocompatibility, combined cancer therapies and theragnosis. J. Nanosci. Nanotechnol. 13(4), 2399–2430 (2013).Crossref, Medline, CAS, Google Scholar3 Shau MD, Tseng SJ, Yang TF, Cherng JY, Chin WK. Effect of molecular weight on the transfection efficiency of novel polyurethane as a biodegradable gene vector. J. Biomed. Mat. Res. A 77A(4), 736–746 (2006).Crossref, CAS, Google Scholar4 Chung TH, Wu SH, Yao M et al. The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles 3T3-L1 cells and human mesenchymal stem cells. Biomaterials 28(19), 2959–2966 (2007).Crossref, Medline, CAS, Google Scholar5 Wu SH, Hung Y, Mou CY. Mesoporous silica nanoparticles as nanocarriers. Chem. Comm. 47(36), 9972–9985 (2011.Crossref, Medline, CAS, Google Scholar6 Meng H, Mai WX, Zhang HY et al. Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo. ACS Nano 7(2), 994–1005 (2013).Crossref, Medline, CAS, Google Scholar7 Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4), 663–676 (2006).Crossref, Medline, CAS, Google Scholar8 Kumagai H, Suemori H, Uesugi M, Nakatsuji N, Kawase E. Identification of small molecules that promote human embryonic stem cell self-renewal. Biochem. Biophys. Res. Comm. 434(4), 710–716 (2013).Crossref, Medline, CAS, Google Scholar9 Wang T, Shi SB, Sha HY. MicroRNAs in regulation of pluripotency and somatic cell reprogramming small molecule with big impact. RNA Biol. 10(8), 1255–1261 (2013).Crossref, Medline, CAS, Google Scholar10 Okita K, Nakagawa M, Hong HJ, Ichisaka T, Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 322(5903), 949–953 (2008).Crossref, Medline, CAS, Google Scholar11 Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat. Rev. Genetics 4(5), 346–358 (2003).Crossref, Medline, CAS, Google Scholar12 Luten J, van Nostrum CF, De Smedt SC, Hennink WE. Biodegradable polymers as non-viral carriers for plasmid DNA delivery. J. Control. Release 126(2), 97–110 (2008).Crossref, Medline, CAS, Google Scholar13 Guan JJ, Fujimoto KL, Sacks MS, Wagner WR. Preparation and characterization of highly porous, biodegradable polyurethane scaffolds for soft tissue applications. Biomaterials 26(18), 3961–3971 (2005).Crossref, Medline, CAS, Google Scholar14 Liu XY, Ho WY, Hung WJ, Shau MD. The characteristics and transfection efficiency of cationic poly (ester-co-urethane) - short chain PEI conjugates self-assembled with DNA. Biomaterials 30(34), 6665–6673 (2009).Crossref, Medline, CAS, Google Scholar15 Ruan J, Shen J, Wang Z et al. Efficient preparation and labeling of human induced pluripotent stem cells by nanotechnology. Int. J. Nanomed. 6, 425–435 (2011).Crossref, Medline, CAS, Google Scholar16 Lee CH, Kim JH, Lee HJ et al. The generation of iPS cells using non-viral magnetic nanoparticle based transfection. Biomaterials 32(28), 6683–6691 (2011).Crossref, Medline, CAS, Google Scholar17 Hsiao JK, Tsai CP, Chung TH et al. Mesoporous silica nanoparticles as a delivery system of gadolinium for effective human stem cell tracking. Small 4(9), 1445–1452 (2008).Crossref, Medline, CAS, Google Scholar18 Lu F, Wu SH, Hung Y, Mou CY. Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Small 5(12), 1408–1413 (2009).Crossref, Medline, CAS, Google Scholar19 Huang XL, Zhang F, Wang H et al. Mesenchymal stem cell-based cell engineering with multifunctional mesoporous silica nanoparticles for tumor delivery. Biomaterials 34(7), 1772–1780 (2013).Crossref, Medline, CAS, Google Scholar20 Ceresa C, Nicolini G, Rigolio R et al. Functionalized mesoporous silica nanoparticles: a possible strategy to target cancer cells reducing peripheral nervous system uptake. Curr. Med. Chem. 20(20), 2589–2600 (2013).Crossref, Medline, CAS, Google Scholar21 Huang DM, Chung TH, Hung Y et al. Internalization of mesoporous silica nanoparticles induces transient but not sufficient osteogenic signals in human mesenchymal stem cells. Toxicol. Appl. Pharmacol. 231(2), 208–215 (2008).Crossref, Medline, CAS, Google Scholar22 Garcia-Bennett AE, Kozhevnikova M, Konig N et al. Delivery of differentiation factors by mesoporous silica particles assists advanced differentiation of transplanted murine embryonic stem cells. Stem Cells Trans. Med. 2(11), 906–915 (2013).Crossref, CAS, Google Scholar23 Chen W, Tsai PH, Hung Y, Chiou SH, Mou CY. Nonviral cell labeling and differentiation agent for induced pluripotent stem cells based on mesoporous silica nanoparticles. ACS Nano 7(10), 8423–8440 (2013).Crossref, Medline, CAS, Google Scholar24 Ichida JK, Blanchard J, Lam K et al. A small-molecule inhibitor of TGF-beta signaling replaces Sox2 in reprogramming by inducing nanog. Cell Stem Cell 5(5), 491–503 (2009).Crossref, Medline, CAS, Google Scholar25 Saunders LR, Sharma AD, Tawney J et al. miRNAs regulate SIRT1 expression during mouse embryonic stem cell differentiation and in adult mouse tissues. Aging (Albany NY) 2(7), 415–431 (2010).Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetailsCited ByTransgene Delivery to Human Induced Pluripotent Stem Cells Using Nanoparticles6 April 2021 | Pharmaceuticals, Vol. 14, No. 4Engineering the niche for hair regeneration — A critical reviewNanomedicine: Nanotechnology, Biology and Medicine, Vol. 15, No. 1Mixed anionic surfactant-templated mesoporous silica nanoparticles for fluorescence detection of Fe 3+1 January 2016 | Dalton Transactions, Vol. 45, No. 25-Azacytidine delivered by mesoporous silica nanoparticles regulates the differentiation of P19 cells into cardiomyocytes1 January 2016 | Nanoscale, Vol. 8, No. 4MicroRNA Replacing Oncogenic Klf4 and c-Myc for Generating iPS Cells via Cationized Pleurotus eryngii Polysaccharide-based Nanotransfection18 August 2015 | ACS Applied Materials & Interfaces, Vol. 7, No. 34 Vol. 9, No. 4 Follow us on social media for the latest updates Metrics Downloaded 99 times History Published online 1 May 2014 Published in print March 2014 Information© Future Medicine LtdKeywordsdirect reprogramminginduced pluripotent stem cellsmesoporous silica nanoparticlesnonviral conversionFinancial & competing interests disclosureThe authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.No writing assistance was utilized in the production of this manuscript.PDF download